[1]
I. Kahkashan, S. Chawdhary, V. R. Tandon, and R. Gupta, “To compare the efficacy and safety of silodosin and dutasteride combination with alfuzosin and dutasteride combination in patients of benign prostatic hyperplasia: a randomized, open label study”, Int J Basic Clin Pharmacol, vol. 8, no. 4, pp. 635–641, Mar. 2019.